none
Conditions
Interventions
G1:4ng/ml remifentanil *2ug/ml propofol
G2:8ng/ml remifentanil *2ug/ml propofol
G3:16ng/ml remifentanil *2ug/ml propofol
G4:4ng/ml remifentanil *3ug/ml propofol
G5:8ng/ml remifentanil *3ug/ml propofol
G6:16ng/ml remifentanil *3ug/ml propofol
G7:4ng/ml remifentanil *6ug/ml propofol
G8:8ng/ml remifentanil *6ug/ml propofol
G9:16ng/ml remifentanil *6ug/ml propofol
Sponsors
The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine)
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Patients aged between 18 and 60 with ASA classification of grade I or II who are scheduled for elective surgery.
Exclusion criteria
Exclusion criteria: Patients with severe liver or kidney dysfunction, neuropsychiatric disorders, a history of psychotropic drug use, implanted pacemakers, thyroid diseases, allergies to remifentanil, propofol, or muscle relaxants, a BMI over 30 kg/m ^2, and those who were pregnant or lactating were excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bispectral index; | — |
Secondary
| Measure | Time frame |
|---|---|
| Mean arterial pressure;Heart rate;Electromyographic activity;Signal Quality Index; | — |
Countries
China
Contacts
Public ContactGuo Xiaowen
The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine)
Outcome results
None listed